MARATTO

article · International Journal of Population Studies

“Does a healthy man need vaccination?”: Attitudes of older adults toward COVID-19 vaccine in South-East Nigeria

20242 citationsOpen accessUniversity of Nigeria

Abstract

The COVID-19 pandemic appears to be impeding the progress of the United Nations’ Sustainable Development Goal and the African Union’s Agenda 2063 in achieving optimal health and well-being for individuals, particularly older adults. Numerous older adults have succumbed to the virus, exacerbating existing global health challenges. In response, scientists worldwide have developed a vaccine to alleviate the substantial disease burden. The Nigerian government has mandated the prioritized vaccination of older adults. This study aims to investigate the attitudes of older adults toward the COVID-19 vaccine. Data were collected from 32 older adults through in-depth interviews and focus group discussions. Thematic analysis was employed to derive meaningful patterns from the collected data. The findings reveal a prevailing lack of awareness among older adults regarding the COVID-19 vaccine. They asserted that they perceived no need for vaccinations, asserting their current state of health. In addition, concerns were raised about potential adverse effects of the vaccine, including the onset of other illnesses. This study suggests that the Nigerian government, through its orientation agencies, undertakes comprehensive public education campaigns highlighting the importance of COVID-19 vaccine uptake.

Research topics

  • Vaccine Coverage and Hesitancy
  • COVID-19 Pandemic Impacts
  • COVID-19 epidemiological studies

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.36922/ijps.359

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.